These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3729478)

  • 41. Concomitant chemoradiotherapy for advanced head and neck cancer.
    Lin JC; Jan JS; Hsu CY
    Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE; Meyer AC; Adams GL; Ondrey FG
    Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The promise of biochemical modulation in combined modality therapy.
    Vokes EE
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):29-33. PubMed ID: 7527598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.
    Kish JA; Benedetti JK; Balcerzak SP; Veith RW; Davis R; Pollock TW; Schuller DE; Ensley JF
    Cancer J Sci Am; 1999; 5(5):307-11. PubMed ID: 10526672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination cisplatin, 5-FU and low-dose radiotherapy in recurrent carcinomas of the head and neck].
    Bolla M; Borgel J; Junien-Lavillauroy ; Sefi A; Guenons A; Lebeau J; Kolodie H; Vincent F
    Bull Cancer; 1986; 73(5):542-4. PubMed ID: 3779135
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Development in the Japan Society of Cancer Research of the Head and Neck Region in the last few years].
    Sakai T
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):550-2. PubMed ID: 5106696
    [No Abstract]   [Full Text] [Related]  

  • 48. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 1991; 12():431-42. PubMed ID: 1931453
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy.
    Nakashima T; Masuda M; Matsui K; Inokuchi A; Kuraoka A; Komiyama S
    Eur Arch Otorhinolaryngol; 1999; 256 Suppl 1():S64-9. PubMed ID: 10337531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraoperative radiation therapy in head and neck cancer.
    Garrett P; Hamaker R; Pugh NO; Ross D; Singer M
    Indiana Med; 1988 Sep; 81(9):780-2. PubMed ID: 3171159
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical evaluation of FAR therapy (radiotherapy with 5FU and vitamin A) for laryngeal cancer. II. Rates of control and complications].
    Jingu K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1261-9. PubMed ID: 4094893
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined treatment of local hyperthermia and irradiation for radioresistant head and neck cancers].
    Fuwa N; Morita K; Okumura E; Horikawa Y; Kimura C; Aoyama K; Muroga M; Yamamoto A
    Rinsho Hoshasen; 1987 Jun; 32(6):687-90. PubMed ID: 3656668
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical evaluation of FAR therapy (radiotherapy with 5FU and vitamin A) for laryngeal cancer. I. Survival rate].
    Jingu K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1253-60. PubMed ID: 4094892
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of HCFU and radiation therapy in head and neck cancer].
    Taketa C
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2169-74. PubMed ID: 3717961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experiences with radiotherapy of malignant tumors in the head-neck-esophagus area using the synchronization effect of 5-FU].
    Dietz R; Wilhelm HJ
    Strahlentherapie Sonderb; 1978; 75():158-61. PubMed ID: 555044
    [No Abstract]   [Full Text] [Related]  

  • 56. The treatment of locally advanced cancer of the head and neck, with special reference to upper jaw tumours.
    Helman P; Sealy R
    J Laryngol Otol; 1976 Jan; 90(1):49-58. PubMed ID: 1255004
    [No Abstract]   [Full Text] [Related]  

  • 57. [New approaches in the treatment of cancer of the head and neck].
    Krajina Z; Markulin-Grgić L; Katić V; Bumber Z; Deponte V
    Chir Maxillofac Plast; 1987; 17(2-3):91-7. PubMed ID: 3483334
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical cancer research in India--present status and future prospects.
    Desai PB
    Indian J Med Res; 1983 Jul; 78 Suppl():8-28. PubMed ID: 6654434
    [No Abstract]   [Full Text] [Related]  

  • 59. Head and neck cancer. Head and Neck Oncology Workgroup, Legislative Task Force on Cancer in Texas.
    Goepfert H; Barker JL; Close LG; el-Domeiri AH; Epley DE; Helfrick JF; Hong WK; Lehane DE; Neal GD; O'Brien JC
    Tex Med; 1987 Sep; 83(9 Pt 2):4-16. PubMed ID: 3672404
    [No Abstract]   [Full Text] [Related]  

  • 60. [Compound therapy including PSK for malignant head and neck cancer].
    Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.